| |
|
Milieu hospitalier
Laboratoires Omega Limitée offre un large éventail de produits injectables destinés au milieu hospitalier. Omega fabrique également plusieurs autres solutions injectables pouvant être exportées ainsi que des produits spécifiques qui répondent aux exigences particulières de certains clients.
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
| Aminophylline |
 fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
 |
Aminophylline injectable USP |
|
Relaxants respiratoires des muscles souples (86:16.00)
|
|
 
|
250mg/10mL (25mg/mL)
|
00582662 |
L0010021 |
10 |
|
|
| |
500mg/10mL (50mg/mL) |
00582654 |
L0010022 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
|
Benztropine OMEGA
|
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
|
Injection de mésylate de benztropine USP
|
|
Agents antiparkinsoniens
(12:08:04)
|
|
|
2mg/2mL (1mg/mL)
|
02238903 |
L0010081 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Calciject® |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Chlorure de calcium pour injection USP, 100mg/mL |
|
Préparations de substitution (40:12)
|
|
|
1000mg/10mL (100mg/mL)
|
00821780 |
L0010058 |
10 |
|
|
| |
5000mg/50mL (100mg/mL) |
00821780 |
L0010059 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CHARAC® |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Charbon activé USP (suspension aqueuse) |
|
Antiacides et adsorbants (56:04)
|
|
|
25g/112.5mL (CHARAC®-25)
|
02056429 |
L0070001 |
25 |
|
|
| |
50g/225mL (CHARAC®-50) |
00637955 |
L0070002 |
20 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CHARAC®-TOL |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Charbon activé USP avec sorbitol 20% (suspension aqueuse) |
|
Antiacides et adsorbants (56:04)
|
|
|
25g/125mL (CHARAC®-TOL 25)
|
02060205 |
L0070003 |
25 |
|
|
| |
50g/250mL (CHARAC®-TOL 50) |
00649236 |
L0070004 |
20 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Baxedin® 0.05% |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Gluconate de chlorhexidine 0,05% p/v (préparation stérile)
Solution antiseptique aqueuse stérile |
|
Divers anti-bactériens locaux (84:04.16)
|
|
| |
avec 4% v/v d’alcool isopropylique USP |
|
|
|
|
110mL
|
00788422 |
L0000006 |
20 |
|
|
| |
500mL
|
00788422 |
L0000001 |
20 |
|
|
| |
1L |
00788422 |
L0000004 |
12 |
|
|
| |
sans alcool isopropylique |
|
|
|
|
|
| |
110mL |
00788422 |
L0000007 |
20 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Baxedin® Pre-Op |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Gluconate de chlorhexidine 0,5% p/v dans 70% v/v d’alcool isopropylique.
Désinfectant |
|
Divers anti-bactériens locaux (84:04.16)
|
|
|
500mL (teintée)
|
01936441 |
L0000003 |
20 |
|
|
| |
500mL (non teintée)
|
01936441 |
L0000015 |
20 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Baxedin® 2% - 70% |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Gluconate de chlorhexidine 2% p/v dans 70% v/v d’alcool isopropylique. |
|
Divers anti-bactériens locaux (84:04.16)
|
|
|
500mL (teintée)
|
02251477 |
L0000018 |
20 |
|
|
| |
500mL (non teintée)
|
02251477 |
L0000017 |
20 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Baxedin® 20%
|
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Gluconate de chlorhexidine BP 20% p/v
Solution aqueuse antiseptique
|
|
Divers anati-bactériens
Locaux (84:04:16)
|
|
|
1 L
|
00658413 |
L0000002 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stanhexidine 2% |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Gluconate de chlorhexidine 2% p/v avec
4% v/v d’alcool isopropylique
Antibactérien peu moussant, nettoyeur pour la peau |
|
Divers anti-bactériens locaux (84:04.16)
|
|
|
450mL
|
01938991 |
L0000012 |
20 |
|
|
| |
4L
|
01938991 |
L0000013 |
1 |
|
|
| |
Gluconate de chlorhexidine 2% p/v aqueux avec
4% v/v d’alcool isopropylique
Antibactérien pour la peau |
|
|
|
| |
450mL |
02246950 |
L0000009 |
20 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stanhexidine 4% |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Gluconate de chlorhexidine 4% p/v avec 4% v/v d’alcool isopropylique
Antibactérien peu moussant, nettoyeur pour la peau |
|
Divers anti-bactériens locaux (84:04.16)
|
|
|
450mL
|
01938983 |
L0000008 |
20 |
|
|
| |
4L
|
01938983 |
L0000014 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Dexamethasone OMEGA |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de phosphate sodique de dexaméthasone USP
|
|
Agents surrénaliens (68:04)
|
|
|
20mg/5mL (4mg/mL)
|
02204266 |
L0010066 |
5 |
|
|
| |
10mg/1mL (100mg/mL) |
02204274 |
L0010094 |
10 |
|
|
| |
100mg/10mL (10mg/mL) |
02204274 |
L0010067 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Sclerodex® |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Dextrose monohydrate USP 250 mg/mL (2500 mg/10 mL) et
Chlorure de sodium USP 100 mg/mL (1000 mg/10 mL) |
|
Agents sclérosants
(24:16)
|
|
|
10mL
|
02020939 |
L0010035 |
5 |
|
|
| |
10mL
|
02020939
|
L0010034
|
50 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Sclerodine® 6 |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Iode, USP 60mg/mL (600mg/10mL) et Iodure de sodium, USP 90mg/mL (900mg/10mL). |
|
Agents sclérosants
(24:16)
|
|
|
10mL
|
02020793 |
L0010037 |
5 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Famotidine OMEGA |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de famotidine
|
|
Divers agents GI (56:40)
Dist. par Hospira au Canada |
|
|
20mg/2mL (10mg/mL)
|
02247735 |
L0010106 |
10 |
|
|
| |
40mg/4mL (10mg/mL) -multidose |
02247745 |
L0010107 |
1 |
|
|
| |
200mg/20mL (10mg/mL) -multidose |
02247745 |
L0010031 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fluconazole OMEGA |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de fl uconazole, 2mg/mL
|
|
Divers agents GI (56:40)
Dist. par Hospira au Canada
|
|
|
200mg/100mL
|
02247749 |
L0010112 |
2 |
|
|
| |
400mg/200mL |
02247749 |
L0010131 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Granisétron
|
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Chlorhydrate de granisétron injectable
|
|
Antagoniste des récepteurs 5-HT3 (56:22.20)
|
|
|
1mg/1mL (1mg granisétron/mL)
|
02322765 |
L0010140 |
5 |
|
|
| |
4mg/4mL (1mg granisétron/mL) |
02322765 |
L0010141
|
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fluphenazine OMEGA |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de décanoate de uphénazine BP
|
|
Agents antipsychotiques (28:16.08)
|
|
|
100mg/1mL (100mg/mL)
|
02242570 |
L0010087 |
5 |
|
|
| |
125mg/5mL (25mg/mL) |
02239636 |
L0010086 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Haloperidol-LA OMEGA |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de décanoate d’halopéridol
|
|
Agents antipsychotiques (28:16.08)
|
|
|
250mg/5mL (50mg/mL)
|
02239639 |
L0010088 |
1 |
|
|
| |
100mg/1mL (100mg/mL) |
02239640 |
L0010095 |
5 |
|
|
| |
500mg/5mL (100mg/mL) |
02239640 |
L0010089 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cas-Mag® |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Hydroxyde de magnésium USP 50mg/mL & extrait aromatique fluide de cascara USP 0,33mL/mL (suspension)
|
|
Purgatifs et laxatifs (56:12)
|
|
|
15mL
|
00874736 |
L0070008 |
25 |
|
|
| |
500mL |
00874736 |
L0070006 |
20 |
|
|
| |
500mg/5mL (100mg/mL) |
00874736 |
L0070007 |
12 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Methacholine OMEGA |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Poudre de chlorure de méthacholine pour solution d’inhalation
|
|
Autres Diagnostiques (36:89.00)
|
|
|
100mg
|
02263890 |
L0030636 |
1 |
|
|
| |
480mg |
02263904 |
L0030637 |
1 |
|
|
| |
1600mg |
02263912 |
L0030638 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Methylene Blue |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de bleu de méthylène USP
|
|
Agents thérapeutiques divers (92:00)
|
|
|
10mg/1mL (10mg/mL)
|
02230770 |
L0010085 |
10 |
|
|
| |
50mg/5mL (10mg/mL) |
02230770 |
L0010072 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mineral Oil |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Huile minérale légère stérile, Normes Omega
|
|
Onguents et protecteurs (84:24.12)
|
|
|
30mL
|
02203375 |
L0010120 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Neostigmine OMEGA |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de méthylsulfate de néostigmine USP
|
|
Agents parasympatho-mimétiques (12:04)
|
|
|
0.5mg/1mL (0.5mg/mL)
|
02230593 |
L0010097 |
10 |
|
|
| |
5mg/10mL (0.5mg/mL)
|
02230593 |
L0010098 |
10 |
|
|
| |
10mg/10mL (1mg/mL) |
02230592 |
L0010096 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nitroject® |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Nitroglycérine injection USP
|
|
Agents vasodilatateurs (24:12)
|
|
|
10mg/10mL (1mg/mL)
|
00614262 |
L0010030 |
5 |
|
|
| |
50mg/10mL (5mg/mL)
|
00778869 |
L0010046 |
5 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Octreotide Acetate OMEGA |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Acétate d’octréotide injectable
|
|
Agents thérapeutiques divers (92:00)
Dist. par Hospira au Canada
|
|
|
50μg/1mL (50μg/mL)
|
02248639 |
L0010115 |
5 |
|
|
| |
100μg/1mL (100μg/mL)
|
02248640 |
L0010116 |
5 |
|
|
| |
500μg/1mL (500μg/mL)
|
02248641 |
L0010117 |
5 |
|
|
| |
1000μg/5mL (200μg/mL) multidose |
02248642 |
L0010118 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ondansetron OMEGA |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Chlorhydrate d’ondansetron dihydraté injectable
|
|
Antagoniste des récepteurs 5-HT3 (56:22.20)
|
|
|
4mg/2mL (2mg/mL)
|
02271761 |
L0010041 |
5 |
|
|
| |
8mg/4mL (2mg/mL)
|
02271761 |
L0010042 |
5 |
|
|
| |
40mg/20mL (2mg/mL) multidose
|
02271788 |
L0010043 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Pamidronate Disodium OMEGA |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Pamidronate disodique pour injection
|
|
Agents thérapeutiques divers (92:00)
|
|
|
30mg/10mL (3mg/mL)
|
02249669 |
L0010102 |
1 |
|
|
| |
60mg/10mL (6mg/mL)
|
02249677 |
L0010123 |
1 |
|
|
| |
90mg/10mL (9mg/mL)
|
02249685 |
L0010103 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phenylephrine |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de chlorhydrate de phényléphrine USP
|
|
Vasopresseur (52:32)
|
|
|
10mg/1mL (10mg/mL - 1%)
|
02238400 |
L0010080 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Scopolamine |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Scopolamine Hydrobromide Injection
|
|
Agents anticholinergique (12:08)
|
|
|
0.4mg/1mL (0.4mg/mL)
|
02242810 |
L0010083 |
10 |
|
|
| |
0.6mg/1mL (0.6mg/mL) |
02242811 |
L0010084
|
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sodium Acetate OMEGA |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection d’acétate de sodium USP
|
|
Préparations de substitution (40:12)
|
|
|
16.4g/50mL (328mg/mL)
|
02181746 |
L0010063 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sodium Chloride |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Chlorure de sodium pour injection USP
|
|
Préparations de substitution (40:12)
|
|
|
9mg/10mL (0.9mg/mL - 0.9%)
|
02150204 |
L0010001 |
10 |
|
|
|
9mg/10mL (0.9mg/mL - 0.9%)
Bactériostatique
|
00402249 |
L0010002 |
10 |
|
|
| |
27mg/30mL (0.9mg/mL - 0.9%) |
02150204 |
L0010071 |
10 |
|
|
| |
27mg/30mL (0.9mg/mL - 0.9%)
Bactériostatique |
00402249 |
L0010003 |
10 |
|
|
| |
45mg/50mL (0.9mg/mL - 0.9%) |
02150204 |
L0010029 |
10 |
|
|
| |
702mg/30mL (23.4mg/mL - 23.4%) |
00402230 |
L0010004 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluant stérile
|
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Chlorure de sodium 0,9% avec phénol 0,5% (diluant stérile)
|
|
Diluants (40:50)
|
|
|
4.5mL
|
00316288 |
L0030006 |
50 |
|
|
| |
9mL |
00316288 |
L0030008 |
50 |
|
|
| |
50mL |
00316288 |
L0030010 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Saliject® |
fiche signalétique PDF |
visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Salicylate de sodium pour injection Normes Omega
|
|
Agents sclérosants (24 :16)
|
|
|
5.7g/10mL (570mg/mL)
|
00623571 |
L0010040 |
5 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Tromboject® 1% & 3% |
fiche signalétique PDF
|
Visuel descriptif PDF
|
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHF |
|
|
Injection de Tétradécyl Sulfate de sodium
|
|
Agents sclérosants
(24 :16)
|
|
|
20mg/2mL (10mg/mL - 1%)
|
00511234 |
L0010049 |
10 |
|
|
| |
60mg/2mL (30mg/mL - 3%)
|
00511226 |
L0010050 |
10
|
|
|
| |
150mg/5mL (30mg/mL - 3%) |
00511226 |
L0010051 |
5 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Thiamiject® |
Fiche signalétique PDF |
Visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS
|
|
|
Injection de chlorhydrate de thiamine USP
|
|
Vitamine Complex B
(88:08)
|
|
|
1000mg/10mL (100mg/mL)
|
02193221 |
L0010061 |
5 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hydrophil® |
Fiche signalétique PDF |
Visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHF |
|
|
Urée à 5% & vaseline blanche à 64,5% (onguent)
|
|
Agents Kératolytiques
(84:28)
|
|
|
200g
|
00566810 |
L0040001 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Water for Injection
|
Fiche signalétique PDF |
Visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFs |
|
|
Eau stérile pour injection USP
|
|
Diluants (40:50)
|
|
|
10mL
|
00402257 |
L0010005 |
10 |
|
|
| |
50mL
|
00402257 |
L0010028 |
10
|
|
|
| |
30mL
Bacteriostatique
|
02131536 |
L0010008 |
10 |
|
|
|
50mL
Bacteriostatique
|
02131536 |
L0010009
|
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Fioles
|
|
Visuel descriptif PDF |
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFs |
|
|
Flacons vides stériles
|
|
Divers
|
|
|
2mL (2-13R) clair
|
|
L0030402 |
100 |
|
|
| |
5mL (5-20R) clair
|
|
L0030404 |
50
|
|
|
| |
10mL (10-20R) clair |
|
L0030406 |
50 |
|
|
| |
10mL (10-20R) ambré |
|
L0030407 |
50 |
|
|
| |
30mL (30-20T) clair |
|
L0030408 |
10 |
|
|
| |
50mL (50-20R) clair |
|
L0030409 |
10 |
|
|
| |
50mL (50-20R) ambré |
|
L0030410 |
10 |
|
|
| |
100mL (100-20R) clair |
|
L0030411 |
12 |
|
|
| |
|
|
|
|
|
|
|
